metformin has been researched along with activins in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslanidis, C; Buechler, C; Filarsky, M; Neumeier, M; Schäffler, A; Schober, F; Schölmerich, J; Schramm, A; Sporrer, D; Stögbauer, F; Wanninger, J; Weber, M; Weigert, J; Wurm, S | 1 |
| Dupont, J; Froment, P; Maillard, V; McNeilly, AS; McNeilly, JR; Rame, C; Tosca, L | 1 |
| Chen, WJ; de Roos, A; Diamant, M; Greulich, S; Lamb, HJ; Lammertsma, AA; Lubberink, M; Ouwens, DM; Rijzewijk, LJ; Romijn, JA; Ruige, JB; Smit, JW; van der Meer, RW | 1 |
| Abdelkhalig, SM; Al-Ammash, BB; El-Dosoky, M; Eladl, MA; Elbayoumi, KS; Elkazaz, AY; Elshormilisy, A; Farag, NE; Galal Gouda, S; Hegazy, A; Mohamed, AS; Mohammad, HMF; Zaitone, SA | 1 |
1 trial(s) available for metformin and activins
| Article | Year |
|---|---|
Activin A is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.
Topics: Activins; Adipose Tissue; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Double-Blind Method; Fluorodeoxyglucose F18; Glucose; Heart; Heart Ventricles; Humans; Hypoglycemic Agents; Inhibin-beta Subunits; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Myocardium; Myocytes, Cardiac; Organ Size; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Thiazolidinediones; Treatment Outcome; Ventricular Remodeling | 2013 |
3 other study(ies) available for metformin and activins
| Article | Year |
|---|---|
Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes.
Topics: Activins; Adiponectin; Aged; Cells, Cultured; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Male; MAP Kinase Signaling System; Metformin; Middle Aged; Monocytes; Obesity; p38 Mitogen-Activated Protein Kinases | 2009 |
Metformin decreases GnRH- and activin-induced gonadotropin secretion in rat pituitary cells: potential involvement of adenosine 5' monophosphate-activated protein kinase (PRKA).
Topics: Acetyl-CoA Carboxylase; Activins; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Enzyme Activation; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Isoenzymes; Luteinizing Hormone; Metformin; Phosphorylation; Pituitary Gland; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Signal Transduction | 2011 |
Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy.
Topics: Activins; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glycoproteins; Kidney; Male; Metformin; Rats; Vascular Endothelial Growth Factor A | 2023 |